View the SEMEDX registration information details.
Back to drug list
ItemsDrug Registration information
ID264
No264
Brand NameSEMEDX
IngredientsSELUMETINIB 10 MG
Dosage FormCAPSULE
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 60'S/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsTO TREAT NEUROFIBROMATOSIS TYPE 1 (NF1, A NERVOUS SYSTEM DISORDER THAT CAUSES TUMORS TO GROW ON NERVES) IN CHILDREN 2 YEARS OF AGE AND OLDER WHO HAVE PLEXIFORM NEUROFIBROMAS (PN; SOFT TUMORS) THAT CANNOT BE COMPLETELY REMOVED BY SYRGERY.
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE CAPSULE CONTAIN LIGHT YELLOW GRANULE
Note
License OwnerBIGBEAR PHARMACEUTICAL LAO CO.,LTD
ManufacturerBIGBEAR PHARMACEUTICAL LAO CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No03 L 1085/24
FDD Registration Date29/03/2024
Expiry Date28/03/2027
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA